Low frequency mutations independently predict poor treatment-free survival in early stage chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis

• Nils Winkelmann,
• Matthew Rose-Zerilli,
• Jade Forster,
• Marina Parry,
• Anton Parker,
• Anne Gardiner,
• Zadie Davies,
• Andrew J. Steele,
• Helen Parker,
• Nicholas C.P. Cross,
• David G. Oscier,
• Jonathan C. Strefford

Affiliations

Nils Winkelmann

Wessex Regional Genetics Laboratory, Salisbury District Hospital, Salisbury, UK;Klinik für Innere Medizin II, Universitätsklinikum Jena, Germany

Matthew Rose-Zerilli

Academic Unit of Cancer Sciences, Faculty of Medicine, University of Southampton, UK

Jade Forster

Academic Unit of Cancer Sciences, Faculty of Medicine, University of Southampton, UK

Marina Parry

Academic Unit of Cancer Sciences, Faculty of Medicine, University of Southampton, UK

Anton Parker

Academic Unit of Cancer Sciences, Faculty of Medicine, University of Southampton, UK;Department of Molecular Pathology, Royal Bournemouth Hospital, Bournemouth, UK

Anne Gardiner

Department of Molecular Pathology, Royal Bournemouth Hospital, Bournemouth, UK

Zadie Davies

Department of Molecular Pathology, Royal Bournemouth Hospital, Bournemouth, UK

Andrew J. Steele

Academic Unit of Cancer Sciences, Faculty of Medicine, University of Southampton, UK

Helen Parker

Academic Unit of Cancer Sciences, Faculty of Medicine, University of Southampton, UK

Nicholas C.P. Cross

Wessex Regional Genetics Laboratory, Salisbury District Hospital, Salisbury, UK;Human Development and Health, Faculty of Medicine, University of Southampton, UK

David G. Oscier

Academic Unit of Cancer Sciences, Faculty of Medicine, University of Southampton, UK;Department of Molecular Pathology, Royal Bournemouth Hospital, Bournemouth, UK

Jonathan C. Strefford

Academic Unit of Cancer Sciences, Faculty of Medicine, University of Southampton, UK